Legal Opinion
Liu v. Boehringer Ingelheim Pharmaceuticals, Inc.
District Court, D. Massachusetts
Decided January 23, 2017No. CIVIL ACTION NO. 14-13234-WGYPublishedCited by 6 opinions
1Opinion of the Court
MEMORANDUM OF DECISION
WILLIAM G. YOUNG, DISTRICT JUDGE
I. INTRODUCTION
This diversity action arises out of the alleged wrongful death of Dr. Zhensheng Liu, due to side effects from taking the prescription drug Pradaxa. Li Liu and Dr. Emily Liu (collectively, the “Lius”), in their capacities as administrators of the estate of Dr. Zhensheng Liu and personal representatives of the heirs-at-law of that estate, have brought claims against the drug’s manufacturers and distributors— Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim USA Corporation, and…
2Cases cited15 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Reeves v. Sanderson Plumbing Products, Inc.Supreme Court of the United States · 2000
- Milissa Garside v. Osco Drug, Inc.Court of Appeals for the First Circuit · 1990
- Wyeth v. LevineSupreme Court of the United States · 2009
10 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Acevedo v. Johnson & JohnsonDistrict Court, D. Massachusetts · 2018
- Corrigan v. Covidien LPDistrict Court, D. Massachusetts · 2024
- JACKSON COUNTY BANK v. DUSABLONDistrict Court, S.D. Indiana · 2020
- Langlois v. American Medical Systems, Inc.District Court, D. Massachusetts · 2020
- Mongeon v. Ethicon, Inc.District Court, D. Massachusetts · 2020
1 more not listed; retrieve them via the Exa API.